At a glance
- Originator Toray
- Developer Toray; University of Arizona
- Class Analgesics
- Mechanism of Action Opioid delta receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 12 Nov 2002 No development reported - Preclinical for Pain in Japan (unspecified route)
- 12 Nov 2002 No development reported - Preclinical for Pain in USA (unspecified route)
- 28 Apr 2000 Profile reviewed but no significant changes made